MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson’s disease

    J. Zhu, L. Zhang (Nanjing, China)

    Objective: The aim of this study was to illuminate the prevalence and clinical correlates of VHs in the Chinese population with PD. Background: Parkinson's disease…
  • 2018 International Congress

    Depression and associated factors in nondemented Chinese patients with Parkinson’s disease

    J. Zhu, L. Zhang (Nanjing, China)

    Objective: This study aimed to estimate the prevalence and identify potential risk factors influencing depression in 519 consecutive nondemented Chinese PD patients. Background: Depression is…
  • 2018 International Congress

    Disrupted Amplitude of Low-frequency Fluctuations and Causal Connectivity in Parkinson’s Disease with Apathy

    Y. Shen, J. Li, Y. Yuan, X. Wang, M. Wang, J. Wang, H. Zhang, L. Zhu, K. Zhang (Nanjing, China)

    Objective: We aimed to explore associated neural substrates changes in Parkinson’s disease (PD) with apathy via amplitude of low-frequency fluctuations (ALFF) and Granger Causality Analysis…
  • 2018 International Congress

    Identifying delirium and it prevalence in idiopathic Parkinson’s disease

    R. Lawson, C. McDonald, D. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: To determine diagnostic criteria used to identify delirium in Parkinson’s disease (PD) and its prevalence via a systematic literature review. Background: People with PD…
  • 2018 International Congress

    Propranolol Induced Visual Hallucinations: A Case Report Charles Bonnets Syndrome in Parkinson Disease

    M. Şenol, M. Kendirli (Istanbul, Turkey)

    Objective: Charles Bonnets has defined the visual hallucinations (VH) associated with macular degeneration; the syndrome (CBS) is to be remembered by his name. M Background:…
  • 2018 International Congress

    Rasagiline as Adjunctive Therapy Induced Impulse Control Disorders in Parkinson’s Disease

    M. Şenol, M. Kendirli (Istanbul, Turkey)

    Objective: In recent years there are an increasing number of impulse control disorders (ICDs), such as pathologic gambling, hypersexuality, compulsive shopping, compulsive eating, punding and…
  • 2018 International Congress

    Intercultural differences in the frequency of impulsive control disorders in Parkinson’s disease

    J. Martinez Castrillo, C. Lastras Fernandez-Escandon, I. Domingez Zabaleta, C. Estevez Fraga, G. Sanchez Diez, A. Alonso Canovas (Madrid, Spain)

    Objective: To study if there were intercultural differences in the prevalence of these impulse control disorders in PD. Background: Impulse control disorders (ICD) era common…
  • 2018 International Congress

    Validation of a One-Page Impulse Control Disorder Questionnaire in a Parkinson’s Disease Clinic

    L. Williams, B. Magennis, N. Feerick, T. Lynch (Dublin, Ireland)

    Objective: We seek to report data on ICD symptoms collected on 120 patients with Parkinsonism attending specialist movement disorder outpatient clinics using a newly devised,…
  • 2018 International Congress

    What can we learn from fMRI capture of visual hallucinations in Parkinson’s disease?

    K. Dujardin, D. Roman, G. Baille, D. Pins, S. Lefebvre, C. Delmaire, L. Defebvre, R. Jardri (Lille, France)

    Objective: To describe the patterns of brain functional changes when visual hallucinations (VH) occur in patients with Parkinson's disease (PD). Background: ​With disease progression, PD…
  • 2018 International Congress

    Patient Experience of Parkinson’s Disease Psychosis Management

    P. Schmidt, F. Cubillos, A. Diaz, P. Wiener, S. Metz, N. Romero, A. Shim, D. Fredericks (Miami, FL, USA)

    Objective: To understand the experience and management of Parkinson’s disease psychosis (PDP). Background: PDP is a troubling non-motor symptom of Parkinson’s disease. Clinical approaches to…
  • « Previous Page
  • 1
  • …
  • 1187
  • 1188
  • 1189
  • 1190
  • 1191
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25676 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley